Category Archives: Nanotech

India is on the world nanotech map, says Prof Dipankar Bandyopadhyay, head of the centre for nanotechnology and professor in the department of chemical engineering at IIT Guwahati. We are doing well in terms of nanoscience and nanotechnology research. In manufacturing and product development, we are doing a cutting-edge job too.

Nanotechnology is the specialised field of work thats carried out at an atomic and molecular scale. It doesnt find as much mention as Indian IT in news coverage, but it is an area where India ranks third in the number of nanotech research articles, behind China and the US. And its share has been gradually rising.

But, Bandyopadhyay says, India still has a lot of ground to cover. Indias 9% contribution to research papers rests in the shadow of the 41% of contributions by China. And in the application of nanotech, India is even further behind. We have the best scientists, but we have our traditional weaknesses in industry, in terms of developing new technologies and having a market where the technology can be implemented. Investors will only show interest when they perceive a market for it, Bandhyopadhyay says.

He says the problem is India is not a big user of technology in products, unlike the US, Europe, China, Japan and South Korea. One exception is the smartphone, which is a product of multiple nanotech processes, including in the body, screen, processors, built-in sensors. Indian society has shown technological dependence on these devices and that created a market for it, Bandhyopadhyay says.

Nanotechnology is essentially about materials manufacturing. Products seemingly as simple as the paint used on cars, anti-reflective coatings on lenses, pregnancy kits, self-leveling epoxy floorings in sports facilities are all results of nanotechnology.

Dipankar Bandyopadhyay, Professor, Department of Chemical Engineering, IIT Guwahati

Go here to see the original:

Indias world No. 3 in nanotech research, but... - Gadgets Now

The fallout from COVID-19 is driving huge investment within AI and nanotechnology, with healthcare investment expected to grow at a rate of nearly 50% more a year towards a market set to be worth $1.333 trillion by 2027, according to Vector Innovation Fund.

The acceleration highlights wide recognition that the world cannot afford the human and economic cost of another pandemic, it says.

At present, 70% of global healthcare provision is spent on providing care for the last few months of our lives.

It is further accepted that the pandemic has shown the inefficiency of the worlds centralised healthcare model and its poor outcomes, with far reaching economic effects and negative impacts on treating cancers, mental health, cardio-vascular conditions, and the emerging challenge from Long COVID.

But observers say this will now trigger the greatest transformation of investment in advanced healthcare technologies since World War II.

These include sophisticated nanotechnology-based diagnostics, biomarkers, vaccines, novel therapies, highly targeted nanomedicines and AI, allowing us to move to a more sustainable, digitised, decentralised and democratised point-of-care environment.

"With dynamic investment these will free our economies and future-proof us from infectious diseases as well as develop solutions to antibiotic resistance, another global healthcare challenge that only technology can solve," VIF says.

"Investors are already switching to this accelerated model, away from traditional healthcare infrastructure and onto point of care and precision medicine.

"This delivers sustainable healthcare economics as well as improving life and longevity. Such investment is expected to bring transformational impact and returns over the next decade and beyond."

This trend was apparent before COVID-19 but investment in healthcare technology in the second half of 2020 has already reached record levels and is set to climb significantly over the next decade.

One particular investment group has developed a unique gateway fund to innovative and disruptive technologies, targeting current and future pandemics, as well as transforming global healthcare.

This international investment platform operated by Vector Innovation Fund G-P Srl, is registered and regulated as an Alternative International Investment Fund, domiciled in Luxembourg due to the country's world class reputation for tax efficiency and regulatory standards. This highly innovative fund is attractive and available only to sophisticated international, UHNW, family office, sovereign wealth, and other institutional investors.

Vector Innovation Fund (VIF) has now launched a $300 million sub-fund for pandemic protection and future healthcare, aiding and supporting precision medicine, highly advanced point of care and AI technologies to support the global economy, sustainable healthcare, and life longevity.

Paul Stannard, chairman and general partner of VIF, says, "Politicians are always forced to defend our old, centralised healthcare model but the pandemic has proved beyond doubt its not fit for purpose.

"A new approach to emerging technologies is vital," he says.

"We have brought together some of the worlds leading figures in biomedicine, advanced diagnostics, nano biomarkers, telemedicine, AI and machine learning to accelerate these transformational technologies into the markets, backed by sophisticated and institutional investors creating one of the most dynamic international investment structures," Stannard explains.

"Globally, we have had to deal with Ebola, Zika Virus, Bird Flu, and now COVID-19 in one decade, but the economy must adapt to a new future, where prevention and early intervention as well as using AI to drive more sustainable models for healthcare and investment."

One example of this is the profound change in telemedicine in just a few months. These technology solutions for GPs and patients, have allowed us to monitor and support many more patients during this pandemic the start of an unstoppable transformation.

Stannard says previous investment criteria were holding back innovation and only reinforcing the broken property-focused and centralised models for healthcare. Innovators have proved that they can develop and commercialise novel technologies and have some approved within months, not years, and this trend will advance beyond the current crisis, which is creating this groundswell of pent-up investment in advanced technologies.

"Our team have an excellent track record in industry, healthcare, technology and investment, with 21 exits and a total value creation of $2.4 billion, including two successful IPOs," he says.

A recent report by KPMG and HFS Research highlighted how companies and governments need to make smart investments in emerging technologies if they are to prevail against future pandemics: 65% of 900 global executives polled said: We don't have a choice or we risk threatening our very existence.

Paul Sheedy, founder of The World Nano Foundation, an international not-for-profit organisation for the commercialisation of nanoscale technologies, adds, "Nanomedicine and the decoding of the genome have been enhancing healthcare for a number of years, but the pandemic has catapulted healthcare investment creating a hockey stick effect for investors.

"This includes vastly improved home testing and advanced diagnostics where we know outcomes are significantly improved through early intervention," he says.

"Added to this, highly targeted precision medicines or therapies are going to transform all forms of healthcare, allowing us to work in parallel with and then ultimately move away from the current archaic centralised healthcare system delivery."

Nanotechnology is forecast to more than double from $54.2 billion this year to $126.8 billion by 2027 and will create a positive force for change when combined with AI and machine learning, forecast on its own to soar 22.5% a year through to 2027 from a $284.38 billion market in 2019.

"We are going to see these twin forces of innovation transform how we live, work, and manage our health in real time as well as develop sustainable models for everything from food production and energy to transport and pollution, all of which improve health and well-being.

"The world of philanthropy and impact investing is also undergoing significant change as we realise that we must advance everything from healthcare for all with more affordable point of care to climate change, improved biodiversity, and reversing pollution."

Naz Bashir, trustee of global technology charity World Science Aid, says, "The world has suddenly woken up to the fact that the global challenges of healthcare, pollution and climate change must now be tackled head on.

"The pandemic has proved that money has no value without sustainable life and a stable economy. The world has reinforced the mistakes of supporting tired funding models for too long, and one positive outcome from the current global crisis is recognition that we now need to invest for the future, and these new technologies can right some of the wrongs of the past.

"For instance, two billion of the worlds seven billion people still do not have access to clean water or simple point of care technology," says Bashir.

"The next generation deserve and demand a better future that these enabling technologies can offer our governments and investors towards building a better post-pandemic future."

Link:

Investment in AI and nanotech surges in wake of COVID-19 - IT Brief New Zealand

NS Nanotech will highlight its ShortWaveLight Emitter technology at the virtual CES consumer electronics exhibition next week.

ANN ARBOR, Mich. (PRWEB) January 05, 2021

Kryptolights is utilizing revolutionary technology in a new suite of commercial and residential products poised to redefine the way we cleanse pathogens from the environment and interact with the world around us. Known as ShortWaveLight Emitters, NS Nanotechs groundbreaking nanotechnology neutralizes coronavirus and other pathogens with far-UVC disinfecting light.

At the virtual CES consumer electronics exhibition next week, NS Nanotech will highlight its ShortWaveLight Emitter technology, including applications that Kryptolights has under development to clean air and surfaces. Registered attendees will be able to visit the NS Nanotech virtual CES booth to learn more (search NS Nanotech in the CES exhibitor directory).

This essential technology is vital to curbing the current pandemic and in preventing one in the future. Many industries could utilize our products to regain peoples trust by offering customers a clean environment to conduct business, explains Kryptolights Co-Founder Shey Godoy. We know this tech will be a big part of the future. This spectrum of light offers normalcy, as it can seamlessly integrate into peoples businesses and lives.

Far UVC: A New Kind of UV Disinfection

The market for disinfection solutions utilizing ultraviolet light is 100 years old. But the COVID-19 pandemic set suppliers in the UV market on fire in 2020 to address the unprecedented disruption to the global economy and daily life for communities worldwide. The range of UV light known as far-UVC can inactivate pathogens, including coronaviruses, by attacking their RNA and making it impossible for them to reproduce. And recent scientific studies have found that with its short wavelength of 230 nanometers or less, far-UVC light does not penetrate living cells on the surfaces of skin and eyes.

Revolutionary solid-state nanotechnologies from NS Nanotech are making it practical to deploy shortwave far-UVC light in many settings, says Godoy. Unlike standard UV bulbs, which operate at high temperatures and require the use of caustic gases, the solid-state ShortWaveLight Emitters run cool, are smaller, and do not use dangerous materials. Whereas previous UV emitters were difficult to operate, now we can bring Kryptolights UltraClean solutions to the market and make a difference in everyones lives.

We are delighted to announce our partnership with Kryptolights on the eve of CES, where we can showcase the revolutionary properties and potential of far-UVC disinfecting light, says NS Nanotech CEO and Co-Founder Seth Coe-Sullivan. We designed our new solid-state far-UVC ShortWaveLight Emitters to be useful for thousands of applications that will protect consumers and businesses from coronavirus and future pathogens. Kryptolights is an early adopter already developing innovative far-UVC disinfection solutions that we expect will have a big impact in the near future and in coming years.

About NS Nanotech

NS Nanotechs patented technologies, drawing on a decade of work on nitride semiconductors by researchers at McGill University and the University of Michigan, dramatically improve the fabrication process and resulting efficiency of nano-scale light-emitting materials. NS Nanotech ShortWaveLight Emitters are the first devices that utilize solid-state semiconductors to generate far-UVC light.

About Kryptolights

Kryptolights is spearheading the advance of Far UVC technology into daily life. Utilizing expertise in spectrum-specific lighting and product brand UltraClean UV, germicidal lighting is coming to the residential and commercial marketplaces through products such as HomeSafe, Cleanse Light, and the Kryptolight Saber.

Share article on social media or email:

Go here to read the rest:

NS Nanotech Teams Up with Kryptolights to Offer Far-UVC Sterilization for a Host of Consumer and Commercial Applications - PR Web

Aerospace Nanotechnology market research report provides detailed information on the following aspects: industry size, share, growth, segmentation, manufacturers and progress, main trends, market drivers, challenges, standardization, deployment models, opportunities, strategies, future roadmaps, and Annual forecast till 2026, etc. The report conducted a professional and in-depth analysis of the current situation of the Aerospace Nanotechnology market, including major players such as manufacturers, suppliers, distributors, traders, customers, and investors. The report also helps you understand the dynamic structure of the Aerospace Nanotechnology market by identifying and analyzing market segments.

Combined with important market challenges, the potential of this industry field has been fully explored. The current market conditions and prospects of this segment have also been checked. In addition, key market strategies including product development, partnerships, mergers, and acquisitions will also be studied. Upstream raw materials and equipment and downstream demand analysis are also conducted.

Have a Need More Info, Request Sample PDF of This Research Report:https://www.worldwidemarketreports.com/sample/337971

The major players profiled in this report include

Airbus, Glonatech, Flight Shield, Lockheed Martin, Lufthansa Technik, tripleO Performance Solution, Zyvex Technologies, CHOOSE NanoTech, General Nano, HR TOUGHGUARD, Metamaterial Technologies

Market Segments and Sub-segments Covered in the Report are as per below:

Based on Product Type Aerospace Nanotechnology market is segmented into

Nanomaterials, Nanotools, Nanodevices

Based on Application Aerospace Nanotechnology market is segmented into

Aircraft Parts, Fuselage Structure, Aero Engine Parts, Aircraft Electronic Communication System, Others

Regional Coverage of the Aerospace Nanotechnology Market:

Europe, Asia Pacific, Africa and Middle East, North America, Latin America

Impact of COVID-19:

The industry is mainly driven by increasing financial incentives and regulatory support from governments around the world. The current Aerospace Nanotechnology market is mainly affected by the COVID-19 pandemic. Most projects in China, the United States, Germany, and South Korea have been postponed. These companies are facing short-term operational problems due to supply chain constraints and the inaccessibility of factories due to the COVID-19 outbreak. Due to the pandemic impact in China, Japan, and India, the spread of COVID-19 is expected to severely affect the Asia-Pacific region.

Get the Covid-19 Impact Analysis, And All updates on Aerospace NanotechnologyIndustry:https://www.worldwidemarketreports.com/covidimpact/337971

Frequently Asked Questions

What does the report cover?The report incorporates an analysis of factors that promote market growth. The report introduces the competitive landscape of the global market. This also provides a range of different market segments and applications that may affect the market in the future. The analysis is based on current market trends and historical growth data. It includes detailed market segmentation, regional analysis, and industry competition pattern.

Does the report estimate the current market size?The report effectively assesses the current market size and provides industry forecasts. The value of this market in 2019 is $XXX million, and the compound annual growth rate during 2020-2026 is expected to be XX%.(*Note: XX values will be given in final report)

How does the report provide the market size of the market?The report effectively assesses the current market size and provides forecasts for the industry in the form of Value (millions USD) and transaction Volume (Thousands Units)

What market dynamics does this report cover?The report shares key insights on:

It helps companies make strategic decisions.

Does this report provide customization?Customization helps organizations gain insight into specific market segments and areas of interest. Therefore, WMR provides customized report information according to business needs for strategic calls.

Customization Link:https://www.worldwidemarketreports.com/quiry/337971

Aerospace Nanotechnology Market 2020-2026: Main Highlights

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends.

Read the original post:

Aerospace Nanotechnology Market Global Industry COVID 19 Analysis, Growth Trends and Forecast 2020-2026: Glonatech, Flight Shield, Lockheed Martin,...

Aerospace Nanotechnology Market research report gives detailed information of industry size, share, growth, segments, manufacturers, and advancements, major trends, market drivers, challenges, standardization, deployment models, opportunities, strategies, future roadmap, and 2026 forecast, etc.The report presents a professional and deep analysis of the present state of Aerospace Nanotechnology Market that includes major players like manufacturers, suppliers, distributors, traders, customers, investors and etc. The report also helps in understanding Aerospace Nanotechnology Market dynamic structure by identifying and analyzing the market segments and project the market size.

Overview Of Aerospace Nanotechnology Market:

The potential of this industry segment has been thoroughly explored in conjunction with essential market challenges. The present market condition and prospects of the segment have also been examined. Moreover, key strategies in the market that includes product developments, partnerships, mergers and acquisitions, etc., are examined. Additionally, upstream raw materials and equipment and downstream demand analysis are likewise conducted.

RequestSample PDF of This Research Report: Click Here!

The Global demand for Aerospace Nanotechnology Market is forecast to report strong development driven by consumption in major evolving markets. More growth opportunities to comes up between 2019 and 2026 compared to a few years ago, signifying the rapid pace of change.

Impact of COVID-19:

Aerospace Nanotechnology Market report analyses the impact of Coronavirus (COVID-19) on the Aerospace Nanotechnology industry. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 180+ countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Aerospace Nanotechnology market in 2020.

COVID-19 can affect the global economy in 3 main ways: by directly affecting production and demand, by creating supply chain and market disturbance, and by its financial impact on firms and financial markets.

The major players profiled in this report include

Airbus, Glonatech, Flight Shield, Lockheed Martin, Lufthansa Technik, tripleO Performance Solution, Zyvex Technologies, CHOOSE NanoTech, General Nano, HR TOUGHGUARD, Metamaterial Technologies

Market Segments and Sub-segments Covered in the Report are as per below:

Based on Product Type Aerospace Nanotechnology market is segmented into

Based on Application Aerospace Nanotechnology market is segmented into

Regional Coverage of the Aerospace Nanotechnology Market:

Competitive Landscape

The report begins with a market overview and moves on to cover the growth prospects of the Aerospace Nanotechnology market. The report covers the details resulting from the analysis of the focused market. The Aerospace Nanotechnology comprises an in the general successful system, confinements, and overall disclosures of the past information along with the present and future needs that may concern the development. The Report provides specific data about the Major factors which are impacting the growth of the Fuels market.

Aerospace Nanotechnology Market report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution, etc., this information help the consumer know about the contenders better. This report also covers all the regions and countries of the world, which shows a regional development status, including business sector size, volume, and value, as well as price data.

Key Offerings of Aerospace Nanotechnology Market Research Report:

The Aerospace Nanotechnology market report provides answers to the following key questions:

Customization:https://www.worldwidemarketreports.com/quiry/449773

We provide customization according to the requirements of our clients needs. Following are some of the options of our customized report: Regional and Country-level analysis of Aerospace Nanotechnology report by end-use.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends.

https://lionlowdown.com/

Follow this link:

Aerospace Nanotechnology Market COVID 19 Increse Factors Outlook, Key Growth Trends on Ke Players and Forecast to 2026: Airbus, Glonatech, Flight...

Nanotechnology is as compelling as it sounds: a field of research dedicated to building devices and materials at the molecular and atomic levels. At that dimension, materials behave differently. And in practical terms, nanotechnology could help increase manufacturing production while cutting costs. The stock market is keen to find the next biggest technology boom, with investors looking for nanotech stocks to buy.

That group includes many names in the semiconductor and industrial sectors. Companies that spent years researching developing nanotechnology-based solutions have huge return potential for investors. Some are familiar names, while others less so.

Here are seven companies that investors should look at today:

Source: Michael Vi / Shutterstock.com

Thermo Fisher Scientific is a diagnostics and research firm with deep interests in material sciences. Its work in transmission electron microscopy and energy-dispersive X-ray spectroscopy will further its understanding of the textile industry. The company said that its nanotechnology studies will lead to adaptable clothing that repels stains, odors, and water.

Smartphones use transistors that are getting smaller and faster. And in medicine, nanoparticles will deliver next-generation drugs and vaccines.

In the third quarter, TMO advanced its cryo-EM for structural biology applications in its electron microscope business. Its new POROS Oligo resin is used to purify and isolate mRNA. Already, the development of mRNA-based vaccines and therapies reached a milestone. The distribution of novel coronavirus vaccines will increase the demand for mRNA production.

For 2020, TMO forecast revenue growing by 20% to around $30.5 billion. Its full-year adjusted earnings per share will increase by 48% to $18.27.

Chart courtesy of Stock Rover

The chart above shows TMO stocks strong quality and growth score. Its nanotech developments will only lift the companys growth prospects next year.

Source: dennizn / Shutterstock.com

Falling behind in the chip processors race for personal computers, Intel is not yet out of the race. The companys chief technology officer, Mike Mayberry, discussed its nanotech ambitions at the international VLSI conference.

Intel will use nanowire/nanoribbon transitions in volume in five years. That timeline will feel like an eternity, especially after the company announced delays in its next-generation chips. Still, these are considered the future of computing. By going beyond FinFET to Gate-All-Around structures, it increases density and high-performance logic.

Investors should note that Intel did not give a clear timeline for this implementation. Besides, its new 7-nanometer process node is still behind schedule. This delay will give its competitors, including Advanced Micro Devices (NASDAQ:AMD) and Taiwan Semiconductor Manufacturing (NYSE:TSM) a sizeable lead.

Data from Stock Rover

As the table above shows, INTC stock is high on quality because of its strong gross margins. That is sustainable, as long as the company catches up in its product refresh.

Source: luchschenF / Shutterstock.com

Arrowhead Pharmaceuticals is focused on discoveries that produced integrated systems of nanotech devices. The Global Nanobiotechnology Industry report said the market has an estimated size of $18.4 billion this year. It cited this company as one of the competitors in this market.

In its core business, the company spent around a decade in bringing RNAi outside the liver. It is building a library of linker chemistry which is used to optimize delivery. By designing potent RNAi triggers, Arrowhead has a TRiM Platform that can treat more patients with its drug candidates. President and CEO Christopher Anzalone said, RNAi doesnt care what gene has been silenced once we validate our ability to reduce expression of a given gene in a given cell type, we have confidence that we can replicate that in other gene targets.

So, if this approach bears fruit, the value of its drug pipeline increases as they get approved, fueling ARWR stock.

Source: Shutterstock

Veeco Instruments is a semiconductor equipment and materials firm specializing in manufacturing 3D transistors and 3D memory. The company decreased its development risks by seeking partners to develop 3nm and 5nm technology node research.

In the third quarter, Veecos data storage unit lifted its revenue to $122 million and non-GAAPS EPS to 22 cents. Although nanotech is not a driver to its growth, VECO stock investors should not get deterred. The company won a deal with Aledia to supply Veecos Propel 300 millimeter MOCVD (metal-organic chemical vapor deposition ) system. MOCVD is a technology used to deposit thin layers of atoms onto a semiconductor wafer. Wafers are made of sapphire or silicon. The customer will use this to manufacture 3D nanowire Micro LED displays.

In the five-year discounted cash flow growth exit model below, the fair value is $21.90:

Model courtesy of finbox

Readers may change the discount or growth rate to re-calculate the stocks price target.

CEO Bill Miller said that its early state micro LED applications will drive its growth in 2022 and beyond. Continued news on this development will likely give VECO stock another lift in the next year.

Source: Shutterstock

Last year, Onto Innovation completed a merger that combined Rudolph Technology with Nanometrics. The deal sought to reduce costs and increase both device performance and product cycle times.

Onto develops process controls. This includes 3D metrology on chips from the nanometer-scale transistors to micro-level die-interconnects. In the third quarter, the company posted revenue of $126.5 million up 101% from last year. It earned 40 cents a share (non-GAAP). In the quarter, customers started using early versions of its Atlas V for the development of node generation as small as 2 nanometers.

In Q4, CEO Michael Plisinski expects growth to accelerate. Demand for the inspection, specialty device, and advanced packaging will remain strong. Its metrology business will also enjoy a rebound in demand.

Based on three analysts, the average price target for ONTO stock is ~$50.00 (per Tipranks).

Source: JHVEPhoto / Shutterstock.com

IBM has at least a two-decade history in nanotechnology research. Its IBM Research division worked in partnership with Singapores Institute of Bioengineering and Nanotechnology. The two firms developed a synthetic polymer that may help increase the effectiveness of existing antibiotics.

IBM stock does reflect the value of the Research division. Despite being a major player in the fields of polymer and materials chemistry, investors are more interested in its developments in artificial intelligence and DevOps. In the near-term, IBMs decision to spin-off its managed infrastructure services business will unlock the stock price discount.

The company is also pivoting to the hybrid cloud market. As it does so, its pace of innovation will increase. And as it creates a competitive advantage, differentiating itself from its peers, investors will buy the stock. So, for now, markets will not notice IBMs contributions to the nanotech segment.

Source: Shutterstock

Trading at close to 52-week highs, basic materials firm DuPont de Nemours may have huge returns ahead. Markets may associate the company with the progress in nanomaterials development.

DuPonts Nutrition and Biosciences division, which it is spinning off through an exchange offer, will interest nanotech investors. Silvadur is a nanoparticle-based silver product. It has silver metal particles that do not easily dissolve in water. This gives it a less uniform finish.

These days, the pandemic is raising awareness of warding away viruses and bacteria. So, demand for Silvadurs antimicrobial fabric surfaces property may increase. Not only is DD stock a potential winning name for investors but so is the spinoff.

Data from Stock Rover

In the table above, the value score suggests that DD stock is trading above fair value. Investors may want to consider holding the Nutrition and Biosciences spinoff instead.

Disclosure:On the date of publication, Chris Lau did not have (either directly or indirectly) any positions in the securities mentioned in this article.

Chris Lau is a contributing author for InvestorPlace.com and numerous other financial sites. Chris has over 20 years of investing experience in the stock market and runs the Do-It-Yourself Value Investing Marketplace on Seeking Alpha. He shares his stock picks so readers get original insight that helps improve investment returns.

Go here to read the rest:

7 Nanotech Stocks To Buy With Huge Returns in Store - Investorplace.com

We knew Far-UV light was a truly unprecedented disinfection tool in the fight against pathogens.

PHOENIX (PRWEB) December 29, 2020

UV Ray Lights is looking to make a big impact in the events business. With hotels, convention centers, and other venues closed in the wake of the global pandemic, gathering in person seemed to give way to the more isolating and economy-crushing reality of digital interactions. With the industry-first introduction of ShortWaveLight, NS Nanotech has developed a revolutionary coronavirus-neutralizing light-emitting technology that will enable UV Ray Lights to pave a way back to in-person meetings.

From the moment the news of a virus terrorizing populations and devastating communities first broke internationally, our company has utilized our experience in specialized lighting to look for a tool in the ultraviolet (UV) spectrum, says UV Ray Lights Co-Founder Ray Stewart. We knew there was power in light, especially in disinfection, and we are excited to be partnering with NS Nanotech to bring real help to the marketplace.

A New Discovery Meets New Tech

Science has known of the special sterilizing qualities of UV light for over 100 years. The range of UV light known commonly as far-UVC can deactivate pathogens, including coronaviruses. And recent scientific studies have found that far-UVC lights short wavelength of 230 nanometers or less does not penetrate living cells on the surfaces of skin and eyes.

We knew Far-UV light was a truly unprecedented tool in the fight against pathogens, continues UV Ray Lights Ray Stewart. The remaining question was what technology could make this UV light available now. That answer could only be NS Nanotech and their ShortWaveLight Emitters.

Utilizing new, cutting-edge solid-state semiconductor technology, NS Nanotech has solved many of the challenging aspects of producing the special shortwave far-UV range of 200-230 nanometers to deactivate pathogens. Unlike standard UV bulbs, which operate at high temperatures and require the use of caustic gases, the solid-state ShortWaveLight Emitters run cool, are small enough to integrate into portable, tabletop devices, and do not use dangerous gases.

Renting Far-UV Light for Functions, Meetings, and Conventions

UV Ray Lights will rent out tabletop UltraClean sterilizers equipped with the ShortWaveLight Emitters to meeting and event organizers. Each device assigned to an attendee at an event will sterilize surfaces and air in front of it, reducing the viral load in the room.

Now we are ready to deploy a real tool to help curb the rising infection rates not only of the current pandemic, but from other viruses and germs people share when they gather for conferences or conventions. Scientific studies are coming out consistently now showing that the real potential of this technology is just emerging, says Stewart. We are excited to be on the forefront of bringing it to the marketplace through our unique rental service. It will now be possible for businesses and industry to gather together for networking, education, and other important in-person events.

We are delighted that UV Ray Lights will help get people back together again by extending the power of our far-UVC ShortWaveLight Emitters to public and private gatherings around the country, says Victor Hsia, NS Nanotechs VP of Business Development and Sales. UV Ray Lights is pioneering the use of a vital new technology in the fight against current and future pandemics.

About UV Ray Lights

UV Ray Lights utilizes years of experience in specialized lighting to bring a safer UV germicidal light to events. Through collaboration with NS Nanotech and Kryptolights, UltraClean UV can be deployed at an array of events, from conferences to conventions. UV Ray Lights is committed to bringing this new tool to venues and events across the country, allowing people to interact and live more freely.

About NS Nanotech

NS Nanotechs patented technologies, drawing on a decade of work on nitride semiconductors by researchers at McGill University and the University of Michigan, dramatically improve the fabrication process and resulting efficiency of nano-scale light-emitting materials. NS Nanotech ShortWaveLight Emitters are the first devices that utilize solid-state semiconductors to generate far-UVC light.

Share article on social media or email:

Read the original:

NS Nanotech and UV Ray Lights Partner to Bring New UV Tech to Conferences and Corporate Events - PR Web

LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sona Nanotech Inc. (Sona or the Company) (OTC: SNANF) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Sona announced on October 29, 2020, that the FDA had denied its request for an emergency use authorization to market its rapid COVID-19 antigen test in the United States. The Companys shares fell 48% on the same day. Then on November 25, 2020, the Company announced the withdrawal of an Interim Order authorization from Health Canada for the marketing of its rapid, COVID-19 antigen test in order to obtain more clinical data to augment its submission. Based on this news, shares of Sona fell by more than 67% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at http://www.schallfirm.com, or by email at brian@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Continue reading here:

INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Sona Nanotech Inc. and Encourages Investors with Losses of...

In what is a major blow to shareholders of Sona Nanotech (CSE: SONA), the company this afternoon announced that it has withdrawn its rapid COVID-19 antigen application from Health Canada based on feedback it has received from the regulatory agency. The move is being conducted in order to obtain more clinical data to augment its submission.

While the application for approval has been withdrawn, the company indicate that it will continue to pursue approval of the test from the agency, which is a nasal swab-type test. Sona is also reportedly continuing to validate its saliva-based version of the rapid test. Now, the company will be looking to conduct a large scale trial for this saliva-based test.

Despite withdrawing its application for an interim order authorization from Health Canada for the marketing of its test, the company continued to state within the news release that its COVID-19 antigen test offers results within 15 minutes. The company also reiterated that testing has shown an agreement with RT-PCR tests 85% of the time, along with 96% sensitivity.

Commenting on the withdrawn application, President and chief scientific officer Darren Rowles stated, The regulatory approval path for antigen tests is new with evolving guidelines and Sonas test is unique, creating a challenging environment for test developers and regulators alike. He then followed up that statement by indicating the company is committed to obtaining the data required.

A timeframe for the required data collection to proceed with Health Canada authorizations was not provided by the company. The company has indicated that it intends to resubmit its application as quickly as possible

Sona Nanotech last traded at $3.11 on the CSE.

Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dives stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.

Read more:

Sona Nanotech Withdraws Health Canada Application For COVID-19 Test Due To Feedback From Regulator - The Deep Dive

A company has been launched in Hull to take an award-winning long-lasting antimicrobial solution aimed at easing the Covid crisis to the UK market.

As protective pandemic measures remain at the highest level with the second lockdown coming to an end, Cicada is ready to roll from a new Sutton Fields base.

A subsidiary of Pocklington-headquartered automotive industry specialist Duracare, it has been established after the product - part of a package of nanotechnology solutions for paint and interiors - was found to have the ability to create safe high-touch areas.

Now Cicada has formed a partnership with the Welsh-based distributor, with serious investment to consult, advise and apply in various settings, from offices and care homes to schools and nurseries.

Noel Parkinson, director, said: The coating forms a nano-scale layer of glass over the surface of base materials which not only makes them easier to clean as it repels liquid and dirt, it also provides a protective antimicrobial layer to constantly kill viruses, bacteria, moulds and fungi. The microbe is physically killed as the surface punctures the cells outer wall, rendering it inactive. This product provides a proven minimum 12-month antimicrobial protection to all treated areas.

The active ingredient comes from a break-through by Liquid Guard Technology, which saw it pick up a German innovation award last year.

Dermatologically tested, it has also been classed as excellent in terms of compatibility with skin contact, Mr Parkinson said.

An early adopter of the technology is Hull Collegiate School, where the leadership team felt the extra level of protection for all touch surfaces had potential to reduce the threat of infections.

Deputy head Chris Wainman said: In line with Government guidance we want to provide pupils with ongoing access to their education in school, within the safest possible environment. Local Covid-19 cases were at the highest levels in the UK, therefore the health and safety of pupils and staff has been at the forefront of our decision. The use of this treatment gives us confidence that we are taking every possible measure to protect pupils and their families.

Traditional disinfection and cleaning methods have limitations in busy areas such as walkways, entrances, dining and washroom facilities. Surface disinfection only kills the bacteria and viruses that are present on surfaces at that moment in time. Once the sanitising process is complete and people return to the area, they bring with them transient microbes, that are then immediately deposited through hand-surface-hand contact to any surface touched, and therefore continue the spread of infections.

A team of three has been established, with environments cleared for a six hour period to facilitate the procedure.

See the rest here:

Hull firm's nanotech solution aims to stop Covid spread in its tracks - Business Live